Arvinas, Inc.
ARVNNASDAQHealthcare● Active
$7.15
$-0.27(-3.64%)
Market Cap$461326566
P/E Ratio—
52W High$14.51
52W Low$6.06
Arvinas, Inc. (ARVN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ARVN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.26B | $0.26B | $0.08B | $0.13B | $0.05B |
| Cost of Revenue | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.26B | $0.26B | $0.08B | $0.13B | $0.05B |
| Gross Margin %(computed) | 98.02% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.28B | $0.35B | $0.38B | $0.32B | $0.18B |
| G&A Expenses | $0.09B | $0.17B | $0.10B | $0.08B | $0.06B |
| Total Operating Expenses | $0.37B | $0.51B | $0.48B | $0.39B | $0.24B |
| Operating Income | ($0.11B) | ($0.25B) | ($0.40B) | ($0.26B) | ($0.19B) |
| Operating Margin %(computed) | -43.75% | -94.99% | -511.46% | -200.30% | -351.49% |
| Interest Income | $0.02B | $0.05B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.20B) | ($0.37B) | ($0.26B) | ($0.19B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.02B | $0.00B |
| Net Income | ($0.08B) | ($0.20B) | ($0.37B) | ($0.28B) | ($0.19B) |
| Net Margin %(computed) | -30.77% | -75.51% | -467.90% | -214.99% | -356.34% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.28 | $-2.77 | $-6.62 | $-5.31 | $-3.82 |
| Wtd Avg Shares | 0.06B | 0.07B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.08B) | ($0.24B) | ($0.39B) | ($0.26B) | ($0.18B) |
| EBITDA Margin %(computed) | -28.67% | -92.48% | -502.93% | -194.06% | -340.30% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Arvinas, Inc. data
About Arvinas, Inc. (ARVN) Income Statement
Arvinas, Inc. (ARVN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ARVN reported revenue of $0.26B, gross profit of $0.26B (gross margin 98.02%), and net income of ($0.08B) — a net profit margin of -30.77%.
Frequently asked questions
ARVN · 4 questionsArvinas, Inc. (ARVN) reported revenue of $0.26B for 2025, down 0.3% year-over-year.
ARVN revenueARVN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08